Davidson Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.4M | Buy |
63,689
+806
| +1% | +$359K | 1.27% | 25 |
|
|
2025
Q1 | $30.5M | Buy |
62,883
+1,722
| +3% | +$835K | 1.51% | 17 |
|
|
2024
Q4 | $24.6M | Buy |
61,161
+12,631
| +26% | +$5.09M | 1.2% | 26 |
|
|
2024
Q3 | $22.6M | Buy |
48,530
+2,191
| +5% | +$1.02M | 1.09% | 28 |
|
|
2024
Q2 | $21.7M | Buy |
46,339
+646
| +1% | +$303K | 1.12% | 27 |
|
|
2024
Q1 | $19.1M | Buy |
45,693
+1,174
| +3% | +$491K | 0.99% | 36 |
|
|
2023
Q4 | $18.1M | Sell |
44,519
-18,392
| -29% | -$7.48M | 1.04% | 39 |
|
|
2023
Q3 | $21.9M | Buy |
62,911
+1,318
| +2% | +$458K | 1.39% | 16 |
|
|
2023
Q2 | $21.7M | Buy |
61,593
+275
| +0.4% | +$96.8K | 1.37% | 15 |
|
|
2023
Q1 | $19.3M | Buy |
61,318
+6,415
| +12% | +$2.02M | 1.27% | 19 |
|
|
2022
Q4 | $15.9M | Buy |
54,903
+418
| +0.8% | +$121K | 1.23% | 32 |
|
|
2022
Q3 | $15.8M | Sell |
54,485
-11,337
| -17% | -$3.28M | 1.32% | 22 |
|
|
2022
Q2 | $18.5M | Buy |
65,822
+595
| +0.9% | +$168K | 1.58% | 17 |
|
|
2022
Q1 | $17M | Buy |
65,227
+918
| +1% | +$240K | 1.23% | 26 |
|
|
2021
Q4 | $14.1M | Sell |
64,309
-413
| -0.6% | -$90.7K | 1.01% | 45 |
|
|
2021
Q3 | $11.7M | Buy |
64,722
+2,548
| +4% | +$462K | 0.92% | 52 |
|
|
2021
Q2 | $12.5M | Buy |
+62,174
| New | +$12.5M | 1% | 47 |
|